NY Files Charges Against J&J Over Opioid Marketing

Law360 (September 17, 2020, 9:08 PM EDT) — New York Gov. Andrew Cuomo on Thursday said the state’s financial services department had filed insurance fraud charges against Johnson & Johnson over opioid marketing that downplayed the risks of addiction.  Johnson & Johnson has become the fourth opioid manufacturer accused of insurance […]

Law360 (September 17, 2020, 9:08 PM EDT) — New York Gov. Andrew Cuomo on Thursday said the state’s financial services department had filed insurance fraud charges against Johnson & Johnson over opioid marketing that downplayed the risks of addiction. 

Johnson & Johnson has become the fourth opioid manufacturer accused of insurance fraud by the New York Department of Financial Services over the marketing of opioids. (AP Photo/Chris O’Meara) J&J is the fourth manufacturer charged by the New York Department of Financial Services over the marketing of opioids, according to the governor’s statement. The department claims J&J long had a leading role in creating a dangerous market for opioids for the…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Source Article

Next Post

We're Hopeful That Altisource Asset Management (NYSEMKT:AAMC) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. For example, Altisource Asset Management (NYSEMKT:AAMC) shareholders have done very well over the last year, with the share price soaring by 137%. But while the successes are well known, investors should not ignore the very many unprofitable companies that […]